Hide filtersShow filters × Close Bryan, Garnier & Co acts as Sole Financial Advisor to life insurance platform Quality Insurance Services on its sale to CNP Assurances Bryan, Garnier & Co acts as Sole Financial Advisor to Montagu Private Equity on the acquisition of Maincare Solutions Bryan, Garnier & Co acts as Financial Advisor to Blueberry Therapeutics on its £10 million Series B Fundraising Bryan, Garnier & Co advises TxCell in its strategic review and subsequent EUR72 million sale to Sangamo Therapeutics to create a CAR-Treg leader Bryan, Garnier & Co advises ORPEA Group on the acquisition of Woonzorgnet B.V. in the Netherlands Bryan, Garnier & Co acts as Sole Financial Advisor to Cyclopharma on its sale to Curium Pharma Bryan, Garnier & Co advised Coltene in its acquisition of Kenda Bryan, Garnier & Co acts as Sole Financial Advisor to Five Arrows on their equity investment in CBA Informatique Bryan, Garnier & Co advises Initiative & Finance and ACG Management on the sale of Mediane to Turenne Bryan, Garnier & Co advises Abenex and the management team of Hygeco on their LBO Upon pricing its landmark IPO on Euronext Paris led by Sole Global Coordinator Bryan, Garnier & Co, Symetis is acquired by Boston Scientific for USD 435 million Bryan, Garnier & Co advised Groupe Novasep on its divestiture of TangenX
